1237 related articles for article (PubMed ID: 16999640)
1. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
[TBL] [Abstract][Full Text] [Related]
2. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
[TBL] [Abstract][Full Text] [Related]
3. Risk perception among women receiving genetic counseling: a population-based follow-up study.
Mikkelsen EM; Sunde L; Johansen C; Johnsen SP
Cancer Detect Prev; 2007; 31(6):457-64. PubMed ID: 18061369
[TBL] [Abstract][Full Text] [Related]
4. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
Geller G; Doksum T; Bernhardt BA; Metz SA
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment of first-degree relatives of women with breast cancer: a feasibility study.
Hurt GJ; McQuellon RP; Michielutte R; Conrad DM; Carter S; Anderson H
Oncol Nurs Forum; 2001 Aug; 28(7):1097-104. PubMed ID: 11517843
[TBL] [Abstract][Full Text] [Related]
6. Development of the breast cancer education and risk assessment program.
Snyder LA; Soballe DB; Lahl LL; Nehrebecky ME; Soballe PW; Klein PM
Oncol Nurs Forum; 2003; 30(5):803-8. PubMed ID: 12949593
[TBL] [Abstract][Full Text] [Related]
7. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
Roshanai AH; Rosenquist R; Lampic C; Nordin K
Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
[TBL] [Abstract][Full Text] [Related]
8. Perceived risk of breast cancer among women at average and increased risk.
Haas JS; Kaplan CP; Des Jarlais G; Gildengoin V; Pérez-Stable EJ; Kerlikowske K
J Womens Health (Larchmt); 2005 Nov; 14(9):845-51. PubMed ID: 16313212
[TBL] [Abstract][Full Text] [Related]
9. Addressing the support needs of women at high risk for breast cancer: evidence-based care by advanced practice nurses.
Stacey D; DeGrasse C; Johnston L
Oncol Nurs Forum; 2002 Jul; 29(6):E77-84. PubMed ID: 12096298
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk counseling improves women's functioning.
Bowen DJ; Burke W; McTiernan A; Yasui Y; Andersen MR
Patient Educ Couns; 2004 Apr; 53(1):79-86. PubMed ID: 15062908
[TBL] [Abstract][Full Text] [Related]
11. Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Bottorff JL; Ratner PA; Balneaves LG; Richardson CG; McCullum M; Hack T; Chalmers K; Buxton J
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):89-95. PubMed ID: 11815405
[TBL] [Abstract][Full Text] [Related]
12. Patients' resistance to risk information in genetic counseling for BRCA1/2.
Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K
Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527
[TBL] [Abstract][Full Text] [Related]
13. Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.
Col NF; Chlebowski RT
Menopause; 2008; 15(4 Suppl):804-9. PubMed ID: 18596602
[TBL] [Abstract][Full Text] [Related]
14. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
[TBL] [Abstract][Full Text] [Related]
15. Women's decisions regarding management of breast cancer risk.
MacDonald DJ
Medsurg Nurs; 2002 Aug; 11(4):183-6. PubMed ID: 12219430
[TBL] [Abstract][Full Text] [Related]
16. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
Khabele D; Runowicz CD
Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer prevention: patient decision making and risk communication in the high risk setting.
Ozanne EM; Wittenberg E; Garber JE; Weeks JC
Breast J; 2010; 16(1):38-47. PubMed ID: 19889168
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer.
Tiller K; Meiser B; Gaff C; Kirk J; Dudding T; Phillips KA; Friedlander M; Tucker K
Med Decis Making; 2006; 26(4):360-72. PubMed ID: 16855125
[TBL] [Abstract][Full Text] [Related]
19. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
Watson M; Lloyd S; Davidson J; Meyer L; Eeles R; Ebbs S; Murday V
Br J Cancer; 1999 Feb; 79(5-6):868-74. PubMed ID: 10070883
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.
Wakefield CE; Meiser B; Homewood J; Peate M; Taylor A; Lobb E; Kirk J; Young MA; Williams R; Dudding T; Tucker K;
Breast Cancer Res Treat; 2008 Jan; 107(2):289-301. PubMed ID: 17333332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
